High-flow nasal cannula versus standard oxygen therapy for acute bronchiolitis in infants: a retrospective analytical study

Authors

  • Shahinaz Shobat Department of Pediatrics, AlDhafra Hospital, Ghayathi, Abu Dhabi, United Arab Emirates https://orcid.org/0009-0001-5252-5867
  • Heba Saleh Department of Pediatrics, AlDhafra Hospital, Ghayathi, Abu Dhabi, United Arab Emirates

DOI:

https://doi.org/10.18203/2349-3291.ijcp20261890

Keywords:

Acute bronchiolitis, SOT, HFNC, Respiratory support

Abstract

Background: Acute Bronchiolitis is a highly prevalent lower respiratory tract infectious diseases among infants. Despite accounting for most hospitalizations in children under 5 years, all pharmaceutical treatments have not demonstrated clear efficacy. Thus, management is mostly by oxygen support. High-flow nasal cannula (HFNC) therapy was recently incorporated as an alternative to standard oxygen therapy (SOT). Given the conflicting results, its efficacy in the treatment of acute bronchiolitis remains unclear. Our study aimed to assess the efficacy of HFNC compared with SOT in terms of length of hospital stay, child discomfort and early discharge.

Methods: This retrospective analytical study was conducted at Ghayathi-AlDhafra hospitals, Abu Dhabi, United Arab Emirates, between January 2023 and December 2024. Data were extracted from electronic health records of infants admitted with acute bronchiolitis. All statistical analyses were performed using R version 4.4.1 in RStudio. Between-group comparisons used Fisher’s exact and Mann-Whitney U tests, with multivariable linear and logistic regression models employing bootstrap confidence intervals to assess length of stay and early discharge.

Results: A total of 81 infants (HFNC: n=15; SOT: n=66) were included in the analysis. Median length of stay was significantly longer in the HFNC group compared with SOT (4 (IQR 3-5) vs 3 (IQR 2-3) days; p=0.002) and HFNC use remained independently associated with prolonged hospitalization after adjustment (β=1.31 days; 95% CI 0.41-2.18). Early discharge within 48 hours was less frequent among infants receiving HFNC (13.33% vs 37.88%), although this difference did not reach statistical significance.

Conclusions: Use of HFNC is associated with longer hospital stays, suggesting that early HFNC use does not alter the course of disease in moderate bronchiolitis. Large-scale studies with standardized protocols are needed to accurately assess the efficacy of HFNC in the treatment of bronchiolitis to identify patients who would benefit most.

References

Shi T, McAllister DA, O'Brien KL, Simoes EA, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946-58.

Tian J, Wang XY, Zhang LL, Liu MJ, Ai JH, Feng GS, et al. Clinical epidemiology and disease burden of bronchiolitis in hospitalized children in China: a national cross-sectional study. World J Pediatr. 2023;19(9):851-63.

Alaoui-Inboui FZ, Yakine F, Ahmito O, El Merzouki N, Salimi S, Slaoui B. Mortality Associated with Viral Bronchiolitis in a Pediatric Department: A Retrospective Analysis. Cureus. 2025;17(5):e84571.

Boyd K, McIntosh E, Lewis S, Rodriguez A, Cunningham S. Cost-effective management of bronchiolitis in infants: 90% versus 94% oxygen saturation. Eur Respir J. 2015;46(59):OA1988.

Manti S, Staiano A, Orfeo L, Midulla F, Marseglia GL, Ghizzi C, et al. UPDATE—2022 Italian guidelines on the management of bronchiolitis in infants. Ital J Pediatr. 2023;49(1):19.

Singh A, Avula A, Zahn E. Acute Bronchiolitis. In: StatPearls. Treasure Island (FL): StatPearls.

Franklin D, Fraser JF, Schibler A. Respiratory support for infants with bronchiolitis, a narrative review of the literature. Paediatr res rev. 2019;30:16-24.

Wolfler A, Raimondi G, Pagan de Paganis C, Zoia E. The infant with severe bronchiolitis: from high flow nasal cannula to continuous positive airway pressure and mechanical ventilation. Minerva pediatrica. 2018;70(6):612-22.

Slain KN, Shein SL, Rotta AT. The use of high‐flow nasal cannula in the pediatric emergency department. Jornal de Pediatria (Versão em Português). 2017;93:36-45.

Lee JH, Rehder KJ, Williford L, Cheifetz IM, Turner DA. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med. 2013;39(2):247-57.

Kepreotes E, Whitehead B, Attia J, Oldmeadow C, Collison A, Searles A, et al. High-flow warm humidified oxygen versus standard low-flow nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): an open, phase 4, randomised controlled trial. Lancet. 2017;389(10072):930-9.

Herakal SU, Indi S, Malagi NAN, Thobbi AN. High flow nasal cannula therapy versus standard oxygen therapy in bronchiolitis: a prospective randomized control trial. Int J Contemp Pediatr. 2024;11(8):1097-103.

Durand P, Guiddir T, Kyheng C, Blanc F, Vignaud O, Epaud R, et al. A randomised trial of high-flow nasal cannula in infants with moderate bronchiolitis. Eur Respir J. 2020;56(1):1901926.

Franklin D, Babl FE, Gibbons K, Pham TMT, Hasan N, Schlapbach LJ, et al. Nasal High Flow in Room Air for Hypoxemic Bronchiolitis Infants. Front Pediatr. 2019;7:426.

Moreel L, Proesmans M. High flow nasal cannula as respiratory support in treating infant bronchiolitis: a systematic review. Eur J Pediatr. 2020;179(5):711-8.

Franklin D, Babl FE, Schlapbach LJ, Oakley E, Craig S, Neutze J, et al. A randomized trial of high-flow oxygen therapy in infants with bronchiolitis. New Eng J Med. 2018;378(12):1121-31.

Hilliard TN, Archer N, Laura H, Heraghty J, Cottis H, Mills K, et al. Pilot study of vapotherm oxygen delivery in moderately severe bronchiolitis. Arch Dis Child. 2012;97(2):182-3.

Alexander EC, Wadia T, Ramnarayan P. Effectiveness of high flow nasal Cannula (HFNC) therapy compared to standard oxygen therapy (SOT) and continuous positive airway pressure (CPAP) in bronchiolitis. Paediatr resp rev. 2024;52:3-8.

Luo J, Duke T, Chisti MJ, Kepreotes E, Kalinowski V, Li J. Efficacy of High-Flow Nasal Cannula vs Standard Oxygen Therapy or Nasal Continuous Positive Airway Pressure in Children with Respiratory Distress: A Meta-Analysis. J pediatr. 2019;215:199-208.

Eşki A, Öztürk GK, Turan C, Özgül S, Gülen F, Demir E. High-flow nasal cannula oxygen in children with bronchiolitis: a randomized controlled trial. Pediatr Pulmonol. 2022;57(6):1527-34.

Downloads

Published

2026-06-22

How to Cite

Shobat, S., & Saleh, H. (2026). High-flow nasal cannula versus standard oxygen therapy for acute bronchiolitis in infants: a retrospective analytical study . International Journal of Contemporary Pediatrics, 13(7), 1042–1048. https://doi.org/10.18203/2349-3291.ijcp20261890

Issue

Section

Original Research Articles